Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: ER, PgR, Ki67, p27Kip1, and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab

Fig. 3

Overall survival curve of pCR patients with and without lymph node metastasis. In pCR cases, OS was significantly better in patients without lymph node metastasis than in those with lymph node metastasis (HR = 13.34, p = 0.0002)

Back to article page